Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis
Alejandro Balsa; Petra Díaz del Campo Fontecha; Lucía Silva Fernández; José Valencia Martín; Virginia Nistal Martínez; Fernando León Vázquez; M. Vanesa Hernández Hernández; Héctor Corominas; Rafael Cáliz Cáliz; José María Aguado García; Gloria Candelas Rodríguez; Nora Ibargoyen Roteta; Arturo Martí Carvajal; M. Nieves Plana Farras; Janet Puñal Riobóo; Hye Sang Park; Yolanda Triñanes Pego; Virginia Villaverde García;
Reumatol Clin. 2023;19:533-48
Investigating potential biomarkers and therapeutic targets for patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) through the utilization of cytokine profiling
Akhil Akhil; Rohit Bansal; Jyotsana Kaushal; Aman Sharma; Archana Bhatnagar;
Reumatol Clin. 2025;21:
Impact of the COVID-19 pandemic on psychosocial health in rheumatic patients: A longitudinal study
Laura Cano-García; Sara Manrique-Arija; Rocío Redondo-Rodríguez; Marta Vera-Ruiz; Jose Manuel Lisbona-Montañez; Arkaitz Mucientes-Ruiz; Aimara García-Studer; Fernando Ortiz-Marquez; Natalia Mena-Vázquez; Antonio Fernández-Nebro;
Reumatol Clin. 2024;20:297-304